Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Protagonist Announces Phase 2 Results for Polycythemia Vera Treatment

americanpharmaceuticalreviewMay 13, 2020

Tag: Protagonist Therapeutics , polycythemia vera , PTG-300

PharmaSources Customer Service